Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial
Innovative Therapies for Children with Cancer (ITCC) Consortium, European Association for Neuroblastoma Research (SIOPEN)
Research output: Contribution to journal › Article › peer-review
36Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial'. Together they form a unique fingerprint.